Correlation Between Terns Pharmaceuticals and Axsome Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Axsome Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Axsome Therapeutics.

Diversification Opportunities for Terns Pharmaceuticals and Axsome Therapeutics

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Terns and Axsome is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Axsome Therapeutics go up and down completely randomly.

Pair Corralation between Terns Pharmaceuticals and Axsome Therapeutics

Given the investment horizon of 90 days Terns Pharmaceuticals is expected to under-perform the Axsome Therapeutics. In addition to that, Terns Pharmaceuticals is 1.32 times more volatile than Axsome Therapeutics. It trades about -0.14 of its total potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.17 per unit of volatility. If you would invest  9,011  in Axsome Therapeutics on August 27, 2024 and sell it today you would earn a total of  857.00  from holding Axsome Therapeutics or generate 9.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Terns Pharmaceuticals  vs.  Axsome Therapeutics

 Performance 
       Timeline  
Terns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Axsome Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Axsome Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Axsome Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Terns Pharmaceuticals and Axsome Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Terns Pharmaceuticals and Axsome Therapeutics

The main advantage of trading using opposite Terns Pharmaceuticals and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.
The idea behind Terns Pharmaceuticals and Axsome Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
CEOs Directory
Screen CEOs from public companies around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios